Ajanta Pharma has informed that a meeting of the Board of Directors of the Company will be held on January 28, 2015, to consider and approve the Unaudited Financial Results for the third quarter ended December 31, 2014 (Q3).
The above information is a part of company’s filings submitted to BSE.